1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Ablation of GPR56 Causes β-Cell Dysfunction by ATP Loss through Mistargeting of Mitochondrial VDAC1 to the Plasma Membrane
(
- Contribution to journal › Article
- 2022
-
Mark
The structure of insulin granule core determines secretory capacity being reduced in type-2 diabetes
2022)(
- Working paper/Preprint › Preprint in preprint archive
- 2021
-
Mark
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
2021) In The FEBS Journal(
- Contribution to journal › Scientific review
-
Mark
Elevated circulating follistatin associates with an increased risk of type 2 diabetes
(
- Contribution to journal › Article
- 2020
-
Mark
Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells
(
- Contribution to journal › Article
- 2018
-
Mark
Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production
(
- Contribution to journal › Article
-
Mark
Silencing of the FTO gene inhibits insulin secretion : An in vitro study using GRINCH cells
(
- Contribution to journal › Article
-
Mark
Glutamine-elicited secretion of glucagon-like peptide 1 is governed by an activated glutamate dehydrogenase
(
- Contribution to journal › Article
- 2017
-
Mark
Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
(
- Contribution to journal › Article
-
Mark
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
(
- Contribution to journal › Article